Latest on Plan B
Drug regulators and the maker of an emergency contraceptive medicineagreed yesterday on a plan that could lead within weeks to over-the-counter sales of the morning-after pill.
The two said the manufacturer, Barr Laboratories, would resubmit its application for the birth control pill, Plan B, within two weeks. A spokeswoman for the Food and Drug Administration, Susan Bro, said the agency would act quickly on the application.
Take that, Elisabeth Hasselbeck.